Validation of a Score for the Detection of Subjects with High Risk for Severe High-Altitude Illness.

Purpose: A decision tree based on a clinicophysiological score (severe high-altitude illness (SHAI) score) has been developed to detect subjects susceptible to SHAI. We aimed to validate this decision tree, to rationalize the prescription of acetazolamide (ACZ), and to specify the rule for a progressive acclimatization.

Methods: Data were obtained from 641 subjects in 15 European medical centers before and during a sojourn at high altitude.

Mountaineering experience decreases the net oxygen cost of climbing Mont Blanc (4,808 m).

The purpose of this study was to test the hypothesis that mountaineering experience decreases the net oxygen cost of uphill walking (OCw) on steep mountain trails and in ice and snow conditions. OCw was measured during an ascent of Mont Blanc in eight experienced alpinists and eight non-alpinists who were matched for sex (4 + 4) and low-altitude aerobic power (V(O)(2)(max) 50-55 ml kg(-1) min(-1)). Subjects carried a breath-by-breath gas exchange analyzer and a GPS.